Analysts Have Conflicting Sentiments on These Healthcare Companies: Cytek Biosciences (CTKB), Elanco Animal Health (ELAN) and Atara Biotherapeutics (ATRA)
Atara Biotherapeutics (ATRA) Reports Q1 Loss, Tops Revenue Estimates
Femasys Inc. (FEMY) Reports Q1 Loss, Misses Revenue Estimates
Dynavax Technologies (DVAX) Reports Q1 Loss, Misses Revenue Estimates
Stoke Therapeutics, Inc. (STOK) Reports Q1 Loss, Tops Revenue Estimates
Atara Biotherapeutics, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Annexon (ANNX) to Report Q1 Earnings: What's in the Cards?
BioNTech (BNTX) to Report Q1 Earnings: Is a Beat in Store?
What's in Store for ADMA Biologics (ADMA) in Q1 Earnings?
What's in Store for Puma Biotechnology (PBYI) in Q1 Earnings?
Atara Biotherapeutics, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Analysts Offer Insights on Healthcare Companies: Atara Biotherapeutics (ATRA) and Embecta Corporation (EMBC)
Atara Biotherapeutics’ Profitability Hinges on Partners’ Success with Ebvallo Amid Market Challenges
Atara Biotherapeutics (ATRA) Gets a Buy from TD Cowen
Atara Biotherapeutics (ATRA) Reports Q4 Loss, Tops Revenue Estimates
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.